Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01865032 · ClinicalTrials.gov registry record
Evaluation of CL Detect™ Rapid Test to Detect Cutaneous Leishmaniasis
A clinical trial, sponsored by U.S. Army Medical Research and Development Command.
- Completed
- Registry status
- 150
- Enrollment target
NCT01865032: Completed study, sponsored by U.S. Army Medical Research and Development Command.
NCT01865032 is a clinical trial that has completed, run by U.S. Army Medical Research and Development Command. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01865032 has completed, sponsored by U.S. Army Medical Research and Development Command.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
This study is a single-site trial assessing the specificity of CL Detect™ Rapid Test versus the gold standard for Leishmania diagnosis in the US which is microscopic identification of Leishmania amastigotes in a stained lesion sample.
Primary Outcome
Positive by both the CL Detect™ Rapid Test and microscopy of an index lesion smear for amastigotes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2013-06 |
| Est. Completion | 2014-04 |
What the finished NCT01865032 record still lists
NCT01865032 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01865032 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01865032 about?
NCT01865032 is a clinical study titled "Evaluation of CL Detect™ Rapid Test to Detect Cutaneous Leishmaniasis". This study is a single-site trial assessing the specificity of CL Detect™ Rapid Test versus the gold standard for Leishmania diagnosis in the US which is microscopic identification of Leishmania amastigotes in a stained lesion sample.
What is the current status of trial NCT01865032?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2013-06. Estimated completion is 2014-04.
Who is sponsoring clinical trial NCT01865032?
This trial is sponsored by U.S. Army Medical Research and Development Command, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia